91 results
8-K
EX-99.1
NVCR
NovoCure Ltd
2 May 24
Novocure Reports First Quarter 2024 Financial Results
7:01am
. The Private Securities Litigation Reform Act of 1995 permits this discussion.
Exhibit 99.1
NOVOCURE LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS
8-K
EX-99.1
x10eugp59vy4zx1d
27 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
26ryepw
22 Feb 24
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
7:06am
8-K
EX-99.1
lriy6fdy46z w10j
18 Jan 24
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
7:01am
8-K
EX-99.1
qzt3usja ub9eo2m
9 Jan 24
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
7:00am
8-K
EX-99.1
ns056y47 vod6ctrpg
8 Jan 24
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
7:10am
8-K
EX-99.1
wpbuts
4 Jan 24
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
4:10pm
8-K
EX-99.1
vsw8r0je6387qodz8 ds
28 Nov 23
Regulation FD Disclosure
7:30am
8-K
EX-99.1
4fj cftdne59bmku
26 Oct 23
Novocure Reports Third Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
y9sdz1mq9o z6krjvy
28 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
1idw5451
27 Jul 23
Novocure Reports Second Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
dfhqaxmu uq
21 Jul 23
Regulation FD Disclosure
8:00am